Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 58

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 58
---
 national securities exchange or quoted on OTCQB or OTCQX, our Common Stock and Units comprised of common
stock may be sold only at the fixed price. Notwithstanding our belief that upon the effective date of this registration statement our
Common Stock will satisfy the admission requirements for the OTCQB and our intention to make application for quotation on the OTCQB Market,
we cannot assure you that our Common Stock will be quoted on the OTCQB tier.

<div align='center'>32

CAPITALIZATION</div>

The following table sets forth our cash and cash equivalents and
capitalization as of September 30, 2025:

| ● | on an actual basis; and                                                                                                                  |
| ● | On a pro forma basis                                                                                                                     
 to give effect to the sale by us of 1,562,500 Units at the fixed public offering price of $3.20 per Unit (assuming the sale of all       
 securities offered hereby and assuming no exercise of the IPO Warrants issued in connection with this Primary Offering), after deducting 
 estimated offering expenses payable by us as if the sale of the securities had occurred on September 30, 2025.                           |

You should read this information together with
our consolidated financial statements and related notes, as well as the information set forth under the headings “Use of Proceeds”
and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” appearing elsewhere
in this prospectus.

|                                                                                                                                          |     | As of         
 September 30, 
 2025          |         |   |     |           |         |   |
|:-----------------------------------------------------------------------------------------------------------------------------------------|:----|:--------------|--------:|:--|:----|:----------|--------:|:--|
| U.S. dollars in thousands                                                                                                                |     | Actual        |         |   |     | Pro Forma |         |   |
|                                                                                                                                          |     | -Unaudited    |         |   |     |           |         |   |
| Stockholders’ equity:                                                                                                                    |     |               |         |   |     |           |         |   |
| Preferred stock, $0.001 par value per share; 10,000,000                                                                                  
 shares authorized, none shares issued and outstanding; 10,000,000 shares authorized and none shares issued and outstanding, pro forma;   
 10,000,000 shares authorized and none shares issued and outstanding, pro forma as adjusted                                               |     | $             |       - |